With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen -
HealthCast: Indian Health Service's Modernization Journey Means Replacing HHS’s Oldest Legacy System
Indian Health Service CIO Mitchell Thornbrugh joins HealthCast to talk about ways that IHS is progressing in its modernization program and the need for a patient-centered, human-centered approach to care.
26m listen -
How AI, Digital Transformation in Health Care Compare Around the World
HHS and EU officials contrasted the different frameworks for emerging technology and the challenges that remain.
4m read -
Health Agencies Tout Standards in Data Sharing, Interoperability
Officials from CMS, ONC and HHS spoke about data standards and how to help smaller health organizations make modernization progress.
3m read